Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Westermark, Per ^a   Lundmark, Katarzyna ^b   Westermark, Gunilla T ^b,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONGO RED; DIRECT YELLOW 7; SILVER NITRATE; SYNTHETIC PEPTIDE; THIOFLAVINE; UNCLASSIFIED DRUG; AMYLOID; COLORING AGENT; PEPTIDE; THIAZOLE DERIVATIVE;

AMYLOID A AMYLOIDOSIS; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIREFRINGENCE; CONTROLLED STUDY; FEMALE; FIBER; GREEN BIREFRINGENCE; INFLAMMATION; MOUSE; NANOMEDICINE; NONHUMAN; ANIMAL; CHEMISTRY; DISEASE MODEL; HUMAN; METABOLISM; PATHOLOGY; SPLEEN; TIME;

ANIMALIA; MUS;

AMYLOID; AMYLOIDOSIS; ANIMALS; COLORING AGENTS; CONGO RED; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLAMMATION; MICE; PEPTIDES; SPLEEN; THIAZOLES; TIME FACTORS;

EID: 67650679312     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006041     Document Type: Article

References (35)

1. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, et al. (2007) A primer of amyloid nomenclature. Amyloid 14: 179-183.
2. Husby G, Marhaug G, Dowton B, Sletten K, Sipe JD (1994) Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid 1: 119-137.
3. Steel DM, Whitehead AS (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15: 81-88.
4. Glenner GG (1980) Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med: 302: 1283-1292 & 1333-1343.
5. 2-terminal sequence identity with only one of two serum amyloid protein (apoSAA) gene products. J Exp Med 159: 641-646.
6. Hardt F, Ranløv PJ (1976) Transfer amyloidosis. Int Rev Exp Pathol 16: 273-334.
7. Axelrad MA, Kisilevsky R, Willmer J, Chen SJ, Skinner M (1982) Further characterization of amyloid-enhancing factor. Lab Invest 47: 139-146.
8. Lundmark K, Westermark GT, Nyström S, Murphy CL, Solomon A, et al. (2002) Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 99: 6979-6984.
9. Xing Y, Nakamura A, Chiba T, Kogishi K, Matsushita T, et al. (2001) Transmission of mouse senile amyloidosis. Lab Invest 81: 493-499.
10. Glenner GG, Eanes ED, Bladen HA, Linke RP, Termine JD (1974) β-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 22: 1141-1158.
11. Westermark P (1974) On the nature of the amyloid in human islets of Langerhans. Histochemistry 38: 27-33.
12. Gustavsson Å, Engström U, Westermark P (1991) Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro. Biochem Biophys Res Commun 175: 1159-1164.
13. Rochet J-C, Lansbury PTJ (2000) Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10: 60-68.
14. Jarrett JT, Lansbury PT (1993) Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058.
15. Come JH, Fraser PE, Lansbury PTJ (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 90: 5959-5963.
16. Morozova-Roche LA, Zurdo J, Spencer A, Noppe W, Receveur V, et al. (2000) Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J Struct Biol 130: 339-351.
17. O'Nuallian B, Williams AD, Westermark P, Wetzel R (2004) Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem 279: 17490-17499.
18. Ganowiak K, Hultman P, Engström U, Gustavsson Å, Westermark P (1994) Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem Biophys Res Commun 199: 306-312.
19. Johan K, Westermark GT, Engström U, Gustavsson Å, Hultman P, et al. (1998) Acceleration of AA-amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 95: 2558-2563.
20. Lundmark K, Westermark GT, Olsén A, Westermark P (2005) Protein fibrils in nature can enhance AA amyloidosis in mice: cross-seeding as a disease mechanism. Proc Natl Acad Sci U S A 102: 6098-6102.
21. Ellis-Behnke RG, Liang YX, You SW, Tay DK, Zhang S, et al. (2006) Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci U S A 103: 5054-5059.
22. Bergström J, Engström U, Yamashita T, Ando Y, Westermark P (2006) Surface exposed epitopes and structural heterogeneity of in vivo formed transthyretin amyloid fibrils. Biochem Biophys Res Commun 348: 532-539.
23. Puchtler H, Sweat F, Levine M (1962) On the binding of Congo red by amyloid. J Histochem Cytochem 10: 355-364.
24. Westermark GT, Johnson KH, Westermark P (1999) Staining methods for identification of amyloid in tissue. Meth Enzymol 309: 3-25.
25. Zhang S, Holmes TD, Persio M, Hynes RO, Su X, et al. (1995) Self-complementary oligopeptide matrices support mammalian cell attachment. Biomaterials 16: 1385-1393.
26. Cui D, Kawano H, Takahashi M, Hoshii Y, Setoguchi M, et al. (2002) Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species. Path Int 52: 40-45.
27. Kisilevsky R, Lemieux L, Boudreau L, Yang DS, Fraser P (1999) New clothes for amyloid enhancing factor (AEF): silk as AEF. Amyloid 6: 98-106.
28. Fu X, Korenaga T, Fu L, Xing Y, Guo Z, et al. (2004) Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. FEBS Lett 563: 179-184.
29. Ge F, Yao J, Fu X, Guo Z, Yan J, et al. (2007) Amyloidosis in transgenic mice expressing murine amyloidogenic apolipoprotein A-II (Apoa2c). Lab Invest 87: 633-643.
30. Nguyen J, Baldwin MA, Cohen FE, Prusiner SB (1995) Prion protein peptides induce alpha-helix to beta-sheet conformational transitions. Biochemistry 34: 4186-4192.
31. Päiviö A, Nordling E, Kallberg Y, Thyberg J, Johansson J (2004) Stabilization of discordant helices in amyloid fibril-forming proteins. Protein Sci 13: 1251-1259.
32. Stevens FJ (2004) Hypothetical structure of human serum amyloid A protein. Amyloid 11: 71-80.
33. Petkova AT, Leapman RD, Guo Z, Yau W-M, Mattson MP, et al. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307: 262-265.
34. Makarava N, Baskakov IV (2008) The same primary structure of the prion protein yields two distinct self-propagating states. J Biol Chem 283: 15988-15996.
35. Solomon A, Richey T, Murphy CL, Weiss DT, Wall JS, et al. (2007) Amyloidogenic potential of foie gras. Proc Natl Acad Sci U S A 104: 10998-11001.